PUBLICATIONS
Selected Publications & Professional Contributions
PUBLICATIONS
Selected Publications & Professional Contributions
FIRST AUTHORSHIPS (Original Research Papers)
FIRST AUTHORSHIPS
(Original Research Papers)
Gerschlager W, et al. Natural history and syndromic associations of orthostatic tremor: a
review of 41 patients. Mov Disord 2004;19:788-795.Gerschlager W, et al. Quality of life in patients with orthostatic tremor. J Neurol
2003;2:212-215.Gerschlager W, et al. Quality of life in the stiff-person syndrome. Mov Disord 2002;
17:1064-1067.Gerschlager W, et al. rTMS over the cerebellum can increase corticospinal excitability
through a spinal mechanism involving activation of peripheral nerve fibres. Clin
Neurophysiol 2002;113:1435-1440.Gerschlager W, et al. Effect of treatment with intravenous immunoglobulin on quality of
life in patients with stiff-person syndrome. Mov Disord 2002;17:590-593.Gerschlager W, et al. [123I]β-CIT SPECT distinguishes vascular parkinsonism from
Parkinson’s disease. Mov Disord 2002;17:518-523.Gerschlager W, et al. Decreased corticospinal excitability after subthreshold 1 Hz rTMS
over lateral premotor cortex. Neurology 2001;57:449-455.Gerschlager W, et al. Bilateral subthalamic nucleus stimulation does not improve
prolonged P300 latencies in Parkinson’s disease. J Neurology 2001;248:285-289.Gerschlager W, et al. Electrophysiological, neuropsychological and clinical findings in
multiple sclerosis patients receiving Interferon β-1b. A 1-year follow-up. European
Neurology 2000;44:205-209.Gerschlager W, et al. Bilateral subthalamic nucleus stimulation improves frontal cortex
function in Parkinson’s disease: An electrophysiological study of the contingent negative
variation. Brain 1999;122:2365-2373.Gerschlager W, et al. Language-related hemispheric asymmetry in healthy subjects and
patients with temporal lobe epilepsy as studied by event-related potentials and intracarotid
amobarbital test. Electroenceph clin Neurophysiol 1998;108:274-282.Gerschlager W. Abstract of Dissertation: In-vivo study on the influence of
neurotransmitters on vascular tone. Wien Klin Wochenschr 1994;106:531-533.
FIRST AUTHORSHIPS (Reviews, Case Reports)
FIRST AUTHORSHIPS
(Reviews, Case Reports)
13. Gerschlager W, Brown P. Orthostatic Tremor – a review.
Handbook of Clinical Neurology 2011; 100:457-62.
14. Gerschlager W, Brown P. Myoclonus
(review). Current Opinion in Neurology 2009; 22:414-418.
15. Gerschlager W, Bloem BR.
Hiccups associated with levodopa in Parkinson’s disease. Mov Disord 2009; 24:619-620.
16. Gerschlager W, Bloem BR. Managing pathological gambling in Parkinson’s disease with enteral
levodopa/carbidopa infusions. Mov Disord 2009; 24:1858-1860.
SENIOR AUTHORSHIPS
SENIOR AUTHORSHIPS
- Bloem BR, et al., Gerschlager W. Falls in the elderly. Identification of risk factors. Wien
Klin Wochenschr2001;113:352-62. - 18. Holler I, et al., Gerschlager W. [123I]β-CIT SPECT and clinical characteristics in two
Parkinson’s disease patients associated with camptocormia. European Neurology
2003;50:118-20. - Holler I, et al., Gerschlager W. 5Hz repetitive TMS increases anticipatory motor activity in
the human cortex. Neuroscience Letters 2006;392: 221-225.
CO-AUTHORSHIPS (Selected academic collaborations including Impact Factors)
CO-AUTHORSHIPS
(Selected academic collaborations including Impact Factors)
Includes studies on Neurotransmitters, Whipple’s disease, Deep Brain Stimulation, MRI imaging, and rTMS in Parkinson’s and Dystonia published in journals such as Brain, Neurology, and Journal of Physiology.
- Wolzt M, Gerschlager W, Zweytick B, Sertl K, Eichler HG.
Effects of NPY and VIP on human venous smooth muscle in vivo.
Naunyn Schmiedebergs Arch Pharmacol 1994;350:194–200. (Impact Factor: 2.8) - Schnider P, Reisinger EC, Gerschlager W, Müller C, Berger T, Krejs GJ, Auff E.
Long-term follow-up in cerebral Whipple’s disease.
Eur J Gastroenterol Hepatol 1996;8:899–903. (Impact Factor: 0.8) - Lang W, Cheyne D, Höllinger P, Gerschlager W, Lindinger G.
Electric and magnetic fields of the brain accompanying internal stimulation of movements.
Cognitive Brain Res 1996;3:125–129. (Impact Factor: 2.2) - Lalouschek W, Gerschlager W, Lehrner J, Baumgartner C, Lindinger G, Lang W.
Event-related potentials in patients with temporal lobe epilepsy reveal topography-specific lateralization in relation to the side of the epileptic focus.
Electroenceph Clin Neurophysiol 1998;108:567–576. (Impact Factor: 2.4) - Pirker W, Asenbaum S, Bencsits G, Prayer D, Gerschlager W, Deecke L, Brücke T.
[123I]β-CIT-SPECT in multiple system atrophy, progressive supranuclear palsy and corticobasal degeneration.
Mov Disord 2000;15:1158–1167. (Impact Factor: 2.5) - Touge T, Gerschlager W, Brown P, Rothwell JC.
Are the after-effects of low frequency rTMS on motor cortex excitability due to changes in the efficacy of cortical synapses?
Clin Neurophysiol 2001;112:2138–2145. (Impact Factor: 3.3) - Boers I, Gerschlager W, Stalenhoef PA, Bloem BR.
Falls in the elderly II: Strategies for prevention.
Wien Klin Wochenschr 2001;113:398–407. (Impact Factor: 0.6) - Pirker W, Djamshidian S, Asenbaum S, Gerschlager W, Tribl G, Hoffmann M, Brücke T.
The progression of dopaminergic degeneration in Parkinson’s disease and atypical parkinsonism: A longitudinal beta-CIT SPECT study.
Mov Disord 2002;17:45–53. (Impact Factor: 2.5) - Strens LH, Oliviero A, Bloem BR, Gerschlager W, Rothwell JC, Brown P.
The effects of subthreshold 1 Hz repetitive TMS on cortico-cortical and interhemispheric coherence.
Clin Neurophysiol 2002;113:1279–1285. (Impact Factor: 3.3) - Katzenschlager R, Costa D, Gerschlager W, O’Sullivan J, Zijlmans J, Gacinovic S, Pirker W, Wills A, Bhatia K, Lees AJ, Brown P.
[123I]-FP-CIT-SPECT demonstrates dopaminergic deficit in orthostatic tremor.
Ann Neurol 2003;53:489–496. (Impact Factor: 8.6) - Siebner HR, Filipovic SR, Rowe JB, Cordivari C, Gerschlager W, Rothwell JC, Frackowiak RS, Bhatia KP.
Patients with focal arm dystonia have increased sensitivity to slow-frequency repetitive TMS over the dorsal premotor cortex.
Brain 2003;126:2710–2725. (Impact Factor: 7.3) - Pirker W, Back C, Gerschlager W, Laccone F, Alesch F.
Chronic thalamic stimulation in a patient with spinocerebellar ataxia type 2.
Mov Disord 2003;18:221–225. (Impact Factor: 2.5) - Pirker W, Holler I, Gerschlager W, Asenbaum S, Zettnig G, Brücke T.
Measuring the rate of progression of Parkinson’s disease over a 5-year period with beta-CIT SPECT.
Mov Disord 2003;18:1266–1272. (Impact Factor: 2.5) - Rizzo V, Siebner HR, Modugno N, Pesenti A, Münchau A, Gerschlager W, Webb RM, Rothwell JC.
Shaping the excitability of human motor cortex with premotor rTMS.
J Physiol 2004;15:483–485. (Impact Factor: 4.3) - Filipovic SR, Siebner HR, Rowe JB, Cordivari C, Gerschlager W, Rothwell JC, Frackowiak RS, Bhatia KP.
Modulation of cortical activity by repetitive transcranial magnetic stimulation (rTMS): A review of functional imaging studies and the potential use in dystonia.
Adv Neurol 2004;94:45–52. (Impact Factor: 1.4) - Münchau A, Langosch JM, Gerschlager W, Rothwell J, Orth M, Trimble MR.
Mirtazapine increases cortical excitability in healthy controls and epilepsy patients with major depression.
J Neurol Neurosurg Psychiatry 2005;76:527–533. (Impact Factor: 2.8) - Sauermann S, Standhardt H, Gerschlager W, Lanmüller H, Alesch F.
Kinematic evaluation in Parkinson’s disease using a hand-held position transducer and computerized signal analysis.
Acta Neurochir (Wien) 2005;147:939–945. (Impact Factor: 1.0) - Rowe JB, Siebner H, Filipovic SR, Cordivari C, Gerschlager W, Rothwell JC, Frackowiak R.
Aging is associated with contrasting changes in local and distant cortical connectivity in the human motor system.
Neuroimage 2006;32:747–760. (Impact Factor: 6.3)
BOOKS
• Gerschlager W.: “Alzheimer – The Disease of Forgetting.” A book for relatives and
patients, 270 pages, Maudrich Verlag, Vienna, 01/2008.
• Gerschlager W.: “Parkinson’s Disease. Diagnosis, Symptoms, and Therapy Options. A self-
help guide.” 230 pages, Maudrich Verlag, Vienna, 04/2009. 2nd Edition 2018.